Weighted feature value based Drug Target Protein prediction

International Journal of Computational Biology and Drug Design

Volumn 1, Issue 4, 2008, Pages 422-433

  Hyun, Bo ra ^a   Jung, Hwiesung ^a   Jang, Woo Hyuk ^a   Hoon Jung, Suk ^a   Han, Dong Soo ^a  

^a Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Bayesian decision theory; drug design; drug target protein; DT P; SVM; weighted feature

Indexed keywords

DRUG; DRUG CARRIER; PROTEIN;

ARTICLE; BAYES THEOREM; CLASSIFICATION; DECISION MAKING; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; DRUG EFFECT; DRUG THERAPY; FACTUAL DATABASE; HUMAN; METABOLISM; METHODOLOGY; REPRODUCIBILITY;

BAYES THEOREM; DATABASES, FACTUAL; DECISION MAKING; DOSAGE FORMS; DRUG ADMINISTRATION ROUTES; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; DRUG THERAPY; HUMANS; PHARMACEUTICAL PREPARATIONS; PROTEINS; REPRODUCIBILITY OF RESULTS;

EID: 77949891850     PISSN: 17560756     EISSN: 17560764     Source Type: Journal    
DOI: 10.1504/IJCBDD.2008.022211     Document Type: Article

References (15)

1. Apweiler, R., Bairoch, A., Wu, C.H., Barker, W.C., Boeckmann, B., Ferro, S., Gasteiger, E., Huang, H., Lopez, R., Magrane, M., Martin, M.J., Natale, D.A., O’Donovan, C., Redaschi, N. and Yeh, L-S.L. (2004) ‘UniProt: the universal protein knowledgebase’, Nucleic Acids Research, Vol. 32, Database issue, pp.D115–D119.
2. Burbaum, J.J. and Sigal, N.H. (1997) ‘New technologies for high-throughput screening’, Curr. Opin. Chem. Bio., January, pp.72–78.
3. Carnero, A. (2006) ‘High throughput screening in drug discovery’, Clinical and Translational Ontology, Vol. 8, No. 7, July, pp.482–490.
4. Chan, A.W.E. and Weir, M.P. (2001) ‘Using chemistry to target treatments’, Chemical Innovation, Vol. 31, No. 12, December, pp.12–17.
5. David, J.T. (2007) ‘Drug discovery and delivery in the 21st century’, Medical Principles and Practice, Vol. 16, pp.1–14.
6. Dove, A. (2003) ‘Screening for content – the evolution of high throughput’, National Biotechnology, Vol. 21, pp.859–864.
7. Duda, R.O., Hart, P.E. and Stork, D.G. (2001) Pattern Classification, John Wiley & Sons, Toronto.
8. Fan, R.E., Chen, P.H. and Lin, C-J. (2005) ‘Working set selection using second order information for training SVM’, Journal of Machine Learning Research, Vol. 6, pp.1889–1918.
9. Han, L.Y., Zheng, C.J., Xie, B., Jia, J., Ma, X.H., Zhu, F., Lin, H.H., Chen, X. and Chen, Y.Z. (2007) ‘Support vector machines approach for predicting druggable proteins: recent progress in its exploration and investigation of its usefulness’, Drug Discovery Today, Vol. 12, Nos. 7–8, pp.304–313.
10. NCBI (1988) National Center for Niotechnology Information, http://www.ncbi.nlm.nih.gov/
11. Qingliang, L. and Luhua, L. (2007) ‘Prediction of potential drug targets based on simple sequence properties’, BMCBioinfomatic, Vol. 8, pp.353–363.
12. Theodoridis, S. and Koutroumbas, K. (2006) Pattern Recognition, 3rd ed., Elsevier.
13. Wishart, D.S., Knox, C., Guo, A.C., Shrivastava, S., Hassanali, M., Stothard, P., Chang, Z. and Woolsey, J. (2006) ‘DrugBank: a comprehensive resource for in silico drug discovery and exploration’, Nucleic Acids Res., Vol. 1, No. 34, January, pp.D668–672.
14. Xu, J., Wang, X., Ensign, B., Li, M., Wu, L., Guia, A. and Xu, J. (2001) ‘Ion-channel assay technologies: quo vadis?’, Drug Discovery Today, Vol. 6, No. 24, pp.1278–1287.
15. Eclipse – an open development platform, http://www.eclipse.org